nodes	percent_of_prediction	percent_of_DWPC	metapath
Alvimopan—Urinary retention—Vincristine—peripheral nervous system neoplasm	0.0206	0.0206	CcSEcCtD
Alvimopan—Urinary tract disorder—Tretinoin—peripheral nervous system neoplasm	0.0203	0.0203	CcSEcCtD
Alvimopan—Urinary tract disorder—Isotretinoin—peripheral nervous system neoplasm	0.0203	0.0203	CcSEcCtD
Alvimopan—Urethral disorder—Tretinoin—peripheral nervous system neoplasm	0.0201	0.0201	CcSEcCtD
Alvimopan—Urethral disorder—Isotretinoin—peripheral nervous system neoplasm	0.0201	0.0201	CcSEcCtD
Alvimopan—Urinary tract disorder—Melphalan—peripheral nervous system neoplasm	0.02	0.02	CcSEcCtD
Alvimopan—Connective tissue disorder—Melphalan—peripheral nervous system neoplasm	0.0199	0.0199	CcSEcCtD
Alvimopan—Urethral disorder—Melphalan—peripheral nervous system neoplasm	0.0198	0.0198	CcSEcCtD
Alvimopan—Malnutrition—Topotecan—peripheral nervous system neoplasm	0.018	0.018	CcSEcCtD
Alvimopan—Malnutrition—Tretinoin—peripheral nervous system neoplasm	0.0179	0.0179	CcSEcCtD
Alvimopan—Malnutrition—Isotretinoin—peripheral nervous system neoplasm	0.0179	0.0179	CcSEcCtD
Alvimopan—Flatulence—Isotretinoin—peripheral nervous system neoplasm	0.0176	0.0176	CcSEcCtD
Alvimopan—Flatulence—Tretinoin—peripheral nervous system neoplasm	0.0176	0.0176	CcSEcCtD
Alvimopan—Hypokalaemia—Cisplatin—peripheral nervous system neoplasm	0.0174	0.0174	CcSEcCtD
Alvimopan—Back pain—Topotecan—peripheral nervous system neoplasm	0.0174	0.0174	CcSEcCtD
Alvimopan—Back pain—Tretinoin—peripheral nervous system neoplasm	0.0173	0.0173	CcSEcCtD
Alvimopan—Back pain—Isotretinoin—peripheral nervous system neoplasm	0.0173	0.0173	CcSEcCtD
Alvimopan—Anaemia—Topotecan—peripheral nervous system neoplasm	0.0166	0.0166	CcSEcCtD
Alvimopan—Anaemia—Tretinoin—peripheral nervous system neoplasm	0.0165	0.0165	CcSEcCtD
Alvimopan—Anaemia—Isotretinoin—peripheral nervous system neoplasm	0.0165	0.0165	CcSEcCtD
Alvimopan—Anaemia—Melphalan—peripheral nervous system neoplasm	0.0163	0.0163	CcSEcCtD
Alvimopan—Urinary tract disorder—Alitretinoin—peripheral nervous system neoplasm	0.0153	0.0153	CcSEcCtD
Alvimopan—Urethral disorder—Alitretinoin—peripheral nervous system neoplasm	0.0152	0.0152	CcSEcCtD
Alvimopan—Urinary tract disorder—Vincristine—peripheral nervous system neoplasm	0.0148	0.0148	CcSEcCtD
Alvimopan—Connective tissue disorder—Vincristine—peripheral nervous system neoplasm	0.0147	0.0147	CcSEcCtD
Alvimopan—Urethral disorder—Vincristine—peripheral nervous system neoplasm	0.0147	0.0147	CcSEcCtD
Alvimopan—Malnutrition—Alitretinoin—peripheral nervous system neoplasm	0.0135	0.0135	CcSEcCtD
Alvimopan—Anaemia—Dactinomycin—peripheral nervous system neoplasm	0.0135	0.0135	CcSEcCtD
Alvimopan—Flatulence—Alitretinoin—peripheral nervous system neoplasm	0.0133	0.0133	CcSEcCtD
Alvimopan—Back pain—Alitretinoin—peripheral nervous system neoplasm	0.0131	0.0131	CcSEcCtD
Alvimopan—Urinary tract disorder—Cisplatin—peripheral nervous system neoplasm	0.0131	0.0131	CcSEcCtD
Alvimopan—Connective tissue disorder—Cisplatin—peripheral nervous system neoplasm	0.013	0.013	CcSEcCtD
Alvimopan—Urethral disorder—Cisplatin—peripheral nervous system neoplasm	0.013	0.013	CcSEcCtD
Alvimopan—Dyspepsia—Topotecan—peripheral nervous system neoplasm	0.0129	0.0129	CcSEcCtD
Alvimopan—Dyspepsia—Tretinoin—peripheral nervous system neoplasm	0.0128	0.0128	CcSEcCtD
Alvimopan—Dyspepsia—Isotretinoin—peripheral nervous system neoplasm	0.0128	0.0128	CcSEcCtD
Alvimopan—Gastrointestinal disorder—Topotecan—peripheral nervous system neoplasm	0.0127	0.0127	CcSEcCtD
Alvimopan—Dyspepsia—Melphalan—peripheral nervous system neoplasm	0.0127	0.0127	CcSEcCtD
Alvimopan—Back pain—Vincristine—peripheral nervous system neoplasm	0.0126	0.0126	CcSEcCtD
Alvimopan—Gastrointestinal disorder—Isotretinoin—peripheral nervous system neoplasm	0.0126	0.0126	CcSEcCtD
Alvimopan—Gastrointestinal disorder—Tretinoin—peripheral nervous system neoplasm	0.0126	0.0126	CcSEcCtD
Alvimopan—Constipation—Topotecan—peripheral nervous system neoplasm	0.0126	0.0126	CcSEcCtD
Alvimopan—Anaemia—Alitretinoin—peripheral nervous system neoplasm	0.0125	0.0125	CcSEcCtD
Alvimopan—Constipation—Tretinoin—peripheral nervous system neoplasm	0.0125	0.0125	CcSEcCtD
Alvimopan—Constipation—Isotretinoin—peripheral nervous system neoplasm	0.0125	0.0125	CcSEcCtD
Alvimopan—Gastrointestinal disorder—Melphalan—peripheral nervous system neoplasm	0.0124	0.0124	CcSEcCtD
Alvimopan—Anaemia—Vincristine—peripheral nervous system neoplasm	0.012	0.012	CcSEcCtD
Alvimopan—Urinary tract disorder—Etoposide—peripheral nervous system neoplasm	0.012	0.012	CcSEcCtD
Alvimopan—Urethral disorder—Etoposide—peripheral nervous system neoplasm	0.0119	0.0119	CcSEcCtD
Alvimopan—Malnutrition—Cisplatin—peripheral nervous system neoplasm	0.0115	0.0115	CcSEcCtD
Alvimopan—Flatulence—Cisplatin—peripheral nervous system neoplasm	0.0114	0.0114	CcSEcCtD
Alvimopan—Anaemia—Cisplatin—peripheral nervous system neoplasm	0.0107	0.0107	CcSEcCtD
Alvimopan—Back pain—Etoposide—peripheral nervous system neoplasm	0.0102	0.0102	CcSEcCtD
Alvimopan—Anaemia—Etoposide—peripheral nervous system neoplasm	0.00976	0.00976	CcSEcCtD
Alvimopan—Dyspepsia—Alitretinoin—peripheral nervous system neoplasm	0.00972	0.00972	CcSEcCtD
Alvimopan—Gastrointestinal disorder—Alitretinoin—peripheral nervous system neoplasm	0.00953	0.00953	CcSEcCtD
Alvimopan—Constipation—Alitretinoin—peripheral nervous system neoplasm	0.00944	0.00944	CcSEcCtD
Alvimopan—Gastrointestinal disorder—Vincristine—peripheral nervous system neoplasm	0.00919	0.00919	CcSEcCtD
Alvimopan—Constipation—Vincristine—peripheral nervous system neoplasm	0.0091	0.0091	CcSEcCtD
Alvimopan—Hypokalaemia—Epirubicin—peripheral nervous system neoplasm	0.00895	0.00895	CcSEcCtD
Alvimopan—Hypokalaemia—Doxorubicin—peripheral nervous system neoplasm	0.00828	0.00828	CcSEcCtD
Alvimopan—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.00812	0.00812	CcSEcCtD
Alvimopan—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.00744	0.00744	CcSEcCtD
Alvimopan—Constipation—Etoposide—peripheral nervous system neoplasm	0.00737	0.00737	CcSEcCtD
Alvimopan—Urinary tract disorder—Epirubicin—peripheral nervous system neoplasm	0.00672	0.00672	CcSEcCtD
Alvimopan—Connective tissue disorder—Epirubicin—peripheral nervous system neoplasm	0.00668	0.00668	CcSEcCtD
Alvimopan—Urethral disorder—Epirubicin—peripheral nervous system neoplasm	0.00667	0.00667	CcSEcCtD
Alvimopan—Urinary tract disorder—Doxorubicin—peripheral nervous system neoplasm	0.00621	0.00621	CcSEcCtD
Alvimopan—Connective tissue disorder—Doxorubicin—peripheral nervous system neoplasm	0.00618	0.00618	CcSEcCtD
Alvimopan—Urethral disorder—Doxorubicin—peripheral nervous system neoplasm	0.00617	0.00617	CcSEcCtD
Alvimopan—Malnutrition—Epirubicin—peripheral nervous system neoplasm	0.00592	0.00592	CcSEcCtD
Alvimopan—Flatulence—Epirubicin—peripheral nervous system neoplasm	0.00583	0.00583	CcSEcCtD
Alvimopan—Back pain—Epirubicin—peripheral nervous system neoplasm	0.00573	0.00573	CcSEcCtD
Alvimopan—Malnutrition—Doxorubicin—peripheral nervous system neoplasm	0.00548	0.00548	CcSEcCtD
Alvimopan—Anaemia—Epirubicin—peripheral nervous system neoplasm	0.00547	0.00547	CcSEcCtD
Alvimopan—Flatulence—Doxorubicin—peripheral nervous system neoplasm	0.0054	0.0054	CcSEcCtD
Alvimopan—Back pain—Doxorubicin—peripheral nervous system neoplasm	0.0053	0.0053	CcSEcCtD
Alvimopan—Anaemia—Doxorubicin—peripheral nervous system neoplasm	0.00506	0.00506	CcSEcCtD
Alvimopan—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	0.00425	0.00425	CcSEcCtD
Alvimopan—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	0.00417	0.00417	CcSEcCtD
Alvimopan—Constipation—Epirubicin—peripheral nervous system neoplasm	0.00413	0.00413	CcSEcCtD
Alvimopan—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	0.00393	0.00393	CcSEcCtD
Alvimopan—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.00386	0.00386	CcSEcCtD
Alvimopan—Constipation—Doxorubicin—peripheral nervous system neoplasm	0.00382	0.00382	CcSEcCtD
